Terminology Service for NFDI4Health
All terms in MESH
| Label | Id | Description |
|---|---|---|
| Immunotherapy | D007167 | [Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.] |
| Retinoschisis | D041441 | [A vitreoretinal dystrophy characterized by splitting of the neuroretinal layers. It occurs in two forms: degenerative retinoschisis and X chromosome-linked juvenile retinoschisis., Splitting of the RETINA into two layers at the level of the outer plexiform layer, beginning as a cystic degeneration in the extreme retinal periphery. It usually occurs after 40 years of age and is generally not progressive., X chromosome recessive disorder, found nearly exclusively in males and becoming apparent around puberty. Characterized initially by a cystlike structure involving the FOVEA CENTRALIS, a peripheral retinoschisis occurs in about half the patients.] |
| Retinal Degeneration | D012162 | [A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)] |
| Klk8 protein, rat | C485430 | |
| Prss22 protein, rat | C485431 | |
| Lin7b protein, mouse | C485432 | |
| Cxcl10 protein, mouse | C485433 | |
| Spag4 protein, rat | C485434 | |
| Gas7 protein, mouse | C485435 | |
| 2-tetradecylcyclobutanone | C485436 | |
| Stc2 protein, mouse | C485438 | |
| Stc2 protein, rat | C485439 | |
| WBP4 protein, human | C485420 | |
| DNASE1L3 protein, human | C485421 | |
| RAB11FIP5 protein, human | C485422 | |
| Zfp216 protein, mouse | C485423 | |
| FxC1 protein, rat | C485424 | |
| LAMTOR3 protein, human | C485425 | |
| Plagl2 protein, mouse | C485426 | |
| Plagl2 protein, rat | C485427 |